Correlation between the patients with Hepatitis C Virus and their Health-Related Quality of Life

Background: Hepatitis C virus (HCV) infection is a global health problem and a major cause of morbidity and mortality. The current study aimed to assess the correlation between the patients with the hepatitis C virus and their health-related quality of life. Descriptive design was used. Setting: Carried out at liver virology outpatient. Subject: A convenient sample of two hundred adult patients with HCV newly received Sofosbuvir and Daclatasvir. Tools: Interview questioner and medical data sheet and Short-Form health survey (SF-36) questionnaire. Results: An improvement in the total quality of life this appear through 51.0% of hepatitis patients were poor in quality of life before treatment with Sofosbuvir and Daclatasvir medication while (62.0%) of them become excellent in quality of life after 3 months from treatment with highly statistically significant differences. Also, there was a fair negative association between the duration of disease of the studied patients with their total quality of life measured by short-form of health before administration of treatment with Sofosbuvir and Daclatasvir. Conclusion: The study concluded that the administration of Sofosbuvir and Daclatasvir for patients had positive effect on their quality of life especially for newly diagnosed patients. Recommendation: The study recommended that early screening for hepatitis C to begin early suitable treatment.